Cargando…

A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin

The aim of this study was to investigate the use of different types of microneedles (MNs) and nanocarriers for in vitro skin permeation and in vivo immunization of plasmid DNA encoding ovalbumin (pOVA). In vitro skin permeation studies indicated that hollow MNs had a superior enhancing effect on ski...

Descripción completa

Detalles Bibliográficos
Autores principales: Pamornpathomkul, Boonnada, Wongkajornsilp, Adisak, Laiwattanapaisal, Wanida, Rojanarata, Theerasak, Opanasopit, Praneet, Ngawhirunpat, Tanasait
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291464/
https://www.ncbi.nlm.nih.gov/pubmed/28184159
http://dx.doi.org/10.2147/IJN.S125945
_version_ 1782504785453252608
author Pamornpathomkul, Boonnada
Wongkajornsilp, Adisak
Laiwattanapaisal, Wanida
Rojanarata, Theerasak
Opanasopit, Praneet
Ngawhirunpat, Tanasait
author_facet Pamornpathomkul, Boonnada
Wongkajornsilp, Adisak
Laiwattanapaisal, Wanida
Rojanarata, Theerasak
Opanasopit, Praneet
Ngawhirunpat, Tanasait
author_sort Pamornpathomkul, Boonnada
collection PubMed
description The aim of this study was to investigate the use of different types of microneedles (MNs) and nanocarriers for in vitro skin permeation and in vivo immunization of plasmid DNA encoding ovalbumin (pOVA). In vitro skin permeation studies indicated that hollow MNs had a superior enhancing effect on skin permeation compared with solid MN patches, electroporation (EP) patches, the combination of MN and EP patches, and untreated skin. Upon using hollow MNs combined with nanocarriers for pOVA delivery, the skin permeation was higher than for the delivery of naked pOVA, as evidenced by the increased amount of pOVA in Franz diffusion cells and immunoglobulin G (IgG) antibody responses. When the hollow MNs were used for the delivery of nanocarrier:pOVA complexes into the skin of mice, they induced a stronger IgG immune response than conventional subcutaneous (SC) injections. In addition, immunization of mice with the hollow MNs did not induce signs of skin infection or pinpoint bleeding. Accordingly, the hollow MNs combined with a nanocarrier delivery system is a promising approach for delivering pOVA complexes to the skin for promoting successful immunization.
format Online
Article
Text
id pubmed-5291464
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-52914642017-02-09 A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin Pamornpathomkul, Boonnada Wongkajornsilp, Adisak Laiwattanapaisal, Wanida Rojanarata, Theerasak Opanasopit, Praneet Ngawhirunpat, Tanasait Int J Nanomedicine Original Research The aim of this study was to investigate the use of different types of microneedles (MNs) and nanocarriers for in vitro skin permeation and in vivo immunization of plasmid DNA encoding ovalbumin (pOVA). In vitro skin permeation studies indicated that hollow MNs had a superior enhancing effect on skin permeation compared with solid MN patches, electroporation (EP) patches, the combination of MN and EP patches, and untreated skin. Upon using hollow MNs combined with nanocarriers for pOVA delivery, the skin permeation was higher than for the delivery of naked pOVA, as evidenced by the increased amount of pOVA in Franz diffusion cells and immunoglobulin G (IgG) antibody responses. When the hollow MNs were used for the delivery of nanocarrier:pOVA complexes into the skin of mice, they induced a stronger IgG immune response than conventional subcutaneous (SC) injections. In addition, immunization of mice with the hollow MNs did not induce signs of skin infection or pinpoint bleeding. Accordingly, the hollow MNs combined with a nanocarrier delivery system is a promising approach for delivering pOVA complexes to the skin for promoting successful immunization. Dove Medical Press 2017-01-27 /pmc/articles/PMC5291464/ /pubmed/28184159 http://dx.doi.org/10.2147/IJN.S125945 Text en © 2017 Pamornpathomkul et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Pamornpathomkul, Boonnada
Wongkajornsilp, Adisak
Laiwattanapaisal, Wanida
Rojanarata, Theerasak
Opanasopit, Praneet
Ngawhirunpat, Tanasait
A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin
title A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin
title_full A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin
title_fullStr A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin
title_full_unstemmed A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin
title_short A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin
title_sort combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid dna encoding ovalbumin
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291464/
https://www.ncbi.nlm.nih.gov/pubmed/28184159
http://dx.doi.org/10.2147/IJN.S125945
work_keys_str_mv AT pamornpathomkulboonnada acombinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT wongkajornsilpadisak acombinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT laiwattanapaisalwanida acombinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT rojanaratatheerasak acombinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT opanasopitpraneet acombinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT ngawhirunpattanasait acombinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT pamornpathomkulboonnada combinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT wongkajornsilpadisak combinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT laiwattanapaisalwanida combinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT rojanaratatheerasak combinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT opanasopitpraneet combinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin
AT ngawhirunpattanasait combinedapproachofhollowmicroneedlesandnanocarriersforskinimmunizationwithplasmiddnaencodingovalbumin